Trials / Terminated
TerminatedNCT00581191
Study Evaluating the Safety and Tolerability of Single Ascending Dose (SAD) SLV-351 in Healthy Subjects
Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SLV-351 Administered Orally to Healthy Subjects
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Safety and tolerability of single oral doses in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SLV-351 | SLV-351 capsules taken once |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2008-03-01
- Completion
- 2008-03-01
- First posted
- 2007-12-27
- Last updated
- 2009-08-04
Source: ClinicalTrials.gov record NCT00581191. Inclusion in this directory is not an endorsement.